🔎 Trials Near Me

Utama › Kanser Kepala dan Leher › New York › New York City

Kajian klinikal Kanser Kepala dan Leher di New York City, NY

21 kajian untuk Kanser Kepala dan Leher sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Mengambil pesertaFasa 1/2
  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering, New York
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Mengambil pesertaFasa 2/3
  • Site #0155, New York
  • Site#0142, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06788990

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Hospital, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Mengambil pesertaFasa 1
  • Icahn School of Medicine at Mt. Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07020117

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Mount Sinai, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06657222

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

Mengambil pesertaFasa 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT05544136

Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology

Mengambil pesertaKajian pemerhatian
  • Memorial Sloan Kettering Cancer Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT02507141

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Mengambil pesertaFasa 1
  • Memorial Sloan Kettering Cancer Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Jul 2026 · NCT04722523

A Study of a New PET Scanner in People With Cancer

Mengambil pesertaKajian pemerhatian
  • Memorial Sloan Kettering Cancer Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Jul 2026 · NCT07690917

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Memorial Sloan Kettering Cancer Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05768139

Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations

Mengambil peserta
  • NYU Meyers College of Nursing, New York
  • NYU Langone Perlmutter Cancer Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT06030011

A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy

Mengambil pesertaKajian pemerhatian
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umur 18 hingga 89 · Semua jantina · Dikemas kini 5 Jun 2026 · NCT05207098

Brodalumab in the Treatment of Immune-Related Adverse Events

Mengambil pesertaFasa 1
  • Columbia University Irving Medical Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Mei 2026 · NCT06673329

New MRI Biomarkers in Head and Neck Cancers

Mengambil pesertaKajian pemerhatian
  • Memorial Sloan Kettering Cancer Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Apr 2026 · NCT03483337

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

Mengambil peserta
  • The New York Proton Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Apr 2026 · NCT05313191

Impact of Photobiomodulation (PBM) on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients

Mengambil peserta
  • NYU Langone Health, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Mac 2026 · NCT06708754

Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy

Mengambil peserta
  • Weill Cornell Medicine, New York
Umur 18 hingga 85 · Semua jantina · Dikemas kini 12 Feb 2026 · NCT07405645

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Mengambil pesertaFasa 1/2
  • Weill Cornell Medicine, Cornell University (site 126), New York
Umur 18 hingga 80 · Semua jantina · Dikemas kini 11 Dis 2025 · NCT03556228

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, New York
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Memorial Sloan Kettering, New York
  • Columbia University Herbert Irving Comprehensive Cancer Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Ogo 2025 · NCT04429542

Comprehensive Outcomes for After Cancer Health

Mengambil pesertaSukarelawan sihat dialu-alukan
  • Memorial Sloan Kettering Cancer Center, New York
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Dis 2024 · NCT05349227

Kajian Kanser Kepala dan Leher di bandar lain

Kajian lain di New York City

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.